焦点粘着
小分子
变构调节
酪氨酸激酶
激酶
癌症研究
PTK2
合理设计
化学
信号转导
细胞生物学
生物
蛋白激酶A
受体
生物化学
丝裂原活化蛋白激酶激酶
遗传学
作者
Peng‐Cheng Lv,Kun Chen,Hai‐Liang Zhu
标识
DOI:10.2174/0929867328666210331143827
摘要
Focal Adhesion Kinase (FAK) is a non-receptor tyrosine kinase involved in the process of cell proliferation, survival, migration, and invasion. It has become a promising therapeutic target for the treatment of human metastatic cancers due to its overexpression and/or activation in multiple cancer types. Since FAK is emerging as a potential cancer target because of its overexpression at both the transcriptional and translational level in cancer, different types of FAK inhibitors with diversified scaffolds have been discovered in the past few years. In this review, the progress of recently discovered small molecule FAK inhibitors was summarized. Major efforts have been focused on the rational design and synthesis of small molecule FAK inhibitors, and their structure-activity relationship (SAR) analysis wasalso discussed. Among them, while type I inhibitors remain as the major focuses, type II inhibitors and novel allosteric FAK inhibitors (type III inhibitors) have been developed to improve both potency and selectivity. Meanwhile, novel strategies, such as targeting FAK using inhibitors of protein-protein interactions, were also discovered. Lastly, some insights and perspectives on the future development of FAK inhibitors as anticancer therapeutics have been provided.
科研通智能强力驱动
Strongly Powered by AbleSci AI